Overview The News Flow Neuroscience has launched FL-100 in the US, giving clinicians a new at-home treatment option for adults aged 18 and older with moderate to severe major depressive disorder who a...
Cumulus NeuLogiq Platform Demonstrates Year-Long Home Use in Mild Alzheimer’s Disease Dementia Study
Overview The News Cumulus Neuroscience has published final results from its CNS-101 study in Frontiers in Digital Health, demonstrating the feasibility of using th...
